Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Teladoc ( (TDOC) ) is now available.
Teladoc Health, Inc. announced that long-serving board member Thomas G. McKinley, who has been a director since 2009, notified the company on February 8, 2026, of his intention to retire from the board effective February 20, 2026. The company emphasized that McKinley is stepping down for personal reasons and not due to any disagreement with management, signaling a planned transition in board leadership rather than a sign of internal conflict.
The most recent analyst rating on (TDOC) stock is a Hold with a $5.50 price target. To see the full list of analyst forecasts on Teladoc stock, see the TDOC Stock Forecast page.
Spark’s Take on TDOC Stock
According to Spark, TipRanks’ AI Analyst, TDOC is a Neutral.
Teladoc’s overall stock score reflects significant financial and technical challenges. The company’s persistent losses and negative valuation metrics weigh heavily on the score. While the earnings call provided some positive insights, such as exceeding revenue guidance and international growth, these are overshadowed by the bearish technical indicators and ongoing operational inefficiencies.
To see Spark’s full report on TDOC stock, click here.
More about Teladoc
Teladoc Health, Inc. operates in the telehealth industry, providing virtual medical services that connect patients with healthcare professionals remotely. The company focuses on digital health solutions that aim to broaden access to care and streamline the delivery of medical consultations through technology-enabled platforms.
Average Trading Volume: 5,894,454
Technical Sentiment Signal: Sell
Current Market Cap: $860.7M
Find detailed analytics on TDOC stock on TipRanks’ Stock Analysis page.